 Lauren Sayres
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 10 | 2015 | 196 | 1.810 |
Why?
| | Genetic Testing | 9 | 2015 | 480 | 1.290 |
Why?
| | Cerclage, Cervical | 2 | 2026 | 10 | 1.130 |
Why?
| | Progestins | 2 | 2026 | 65 | 1.090 |
Why?
| | Fetal Growth Retardation | 2 | 2024 | 593 | 1.070 |
Why?
| | Progesterone | 2 | 2026 | 209 | 1.020 |
Why?
| | Amniotic Fluid | 2 | 2024 | 79 | 0.990 |
Why?
| | Premature Birth | 3 | 2026 | 387 | 0.940 |
Why?
| | DNA | 8 | 2014 | 1451 | 0.890 |
Why?
| | Oligohydramnios | 1 | 2024 | 16 | 0.850 |
Why?
| | Chorioamnionitis | 1 | 2023 | 50 | 0.730 |
Why?
| | Ultrasonography, Prenatal | 1 | 2024 | 294 | 0.720 |
Why?
| | Pregnancy | 18 | 2026 | 7197 | 0.680 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2020 | 82 | 0.610 |
Why?
| | Placenta | 2 | 2023 | 784 | 0.610 |
Why?
| | Fetal Diseases | 2 | 2011 | 194 | 0.590 |
Why?
| | Zika Virus Infection | 1 | 2020 | 172 | 0.550 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 437 | 0.470 |
Why?
| | Microbiota | 1 | 2023 | 784 | 0.430 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2014 | 14 | 0.420 |
Why?
| | Trisomy | 1 | 2014 | 78 | 0.390 |
Why?
| | Fetal Viability | 1 | 2012 | 3 | 0.360 |
Why?
| | Preimplantation Diagnosis | 1 | 2012 | 6 | 0.360 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2012 | 6 | 0.360 |
Why?
| | Moral Obligations | 1 | 2012 | 15 | 0.350 |
Why?
| | Fertilization in Vitro | 1 | 2012 | 93 | 0.340 |
Why?
| | Obstetrics | 1 | 2011 | 176 | 0.290 |
Why?
| | Running | 4 | 2015 | 230 | 0.260 |
Why?
| | Attitude of Health Personnel | 2 | 2015 | 1188 | 0.250 |
Why?
| | Female | 22 | 2026 | 78763 | 0.250 |
Why?
| | Cervix Uteri | 1 | 2026 | 50 | 0.240 |
Why?
| | Aneuploidy | 3 | 2015 | 90 | 0.210 |
Why?
| | Decision Making | 1 | 2012 | 979 | 0.210 |
Why?
| | Fetal Heart | 1 | 2024 | 56 | 0.200 |
Why?
| | Parents | 1 | 2012 | 1404 | 0.190 |
Why?
| | Attitude to Health | 3 | 2015 | 431 | 0.180 |
Why?
| | Preconception Care | 1 | 2022 | 50 | 0.180 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 156 | 0.180 |
Why?
| | Humans | 23 | 2026 | 145491 | 0.180 |
Why?
| | Practice Patterns, Physicians' | 1 | 2011 | 1369 | 0.180 |
Why?
| | Fractures, Stress | 2 | 2013 | 31 | 0.180 |
Why?
| | Multivariate Analysis | 1 | 2025 | 1544 | 0.170 |
Why?
| | Reproduction | 1 | 2022 | 207 | 0.170 |
Why?
| | Mosquito Control | 1 | 2020 | 30 | 0.160 |
Why?
| | Mosquito Vectors | 1 | 2020 | 31 | 0.160 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 57 | 0.160 |
Why?
| | Cell-Free System | 4 | 2014 | 53 | 0.160 |
Why?
| | Microcephaly | 1 | 2020 | 105 | 0.150 |
Why?
| | Delivery, Obstetric | 1 | 2020 | 161 | 0.150 |
Why?
| | Tocolysis | 1 | 2019 | 4 | 0.150 |
Why?
| | Tocolytic Agents | 1 | 2019 | 16 | 0.140 |
Why?
| | Obstetric Labor, Premature | 1 | 2019 | 39 | 0.140 |
Why?
| | Prevalence | 2 | 2024 | 2855 | 0.140 |
Why?
| | Endothelial Cells | 1 | 2023 | 866 | 0.130 |
Why?
| | Adult | 6 | 2025 | 40707 | 0.120 |
Why?
| | Maternal Serum Screening Tests | 1 | 2015 | 3 | 0.110 |
Why?
| | Cohort Studies | 1 | 2024 | 5992 | 0.100 |
Why?
| | Pregnancy Trimester, First | 1 | 2014 | 138 | 0.100 |
Why?
| | Bone Density | 2 | 2015 | 484 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6437 | 0.100 |
Why?
| | Blood Grouping and Crossmatching | 1 | 2012 | 19 | 0.090 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2012 | 15 | 0.090 |
Why?
| | Chromosome Aberrations | 1 | 2012 | 164 | 0.090 |
Why?
| | Fetus | 2 | 2013 | 804 | 0.080 |
Why?
| | Genetic Counseling | 1 | 2011 | 81 | 0.080 |
Why?
| | United States | 6 | 2014 | 16115 | 0.080 |
Why?
| | Cumulative Trauma Disorders | 1 | 2011 | 30 | 0.080 |
Why?
| | Blood Chemical Analysis | 1 | 2011 | 110 | 0.080 |
Why?
| | Nurse Midwives | 1 | 2011 | 43 | 0.080 |
Why?
| | Genetic Markers | 1 | 2011 | 334 | 0.080 |
Why?
| | Bone Density Conservation Agents | 1 | 2010 | 81 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2015 | 779 | 0.070 |
Why?
| | Nurse Practitioners | 1 | 2011 | 138 | 0.070 |
Why?
| | Logistic Models | 1 | 2014 | 2130 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2025 | 17269 | 0.070 |
Why?
| | Vitamin D | 1 | 2010 | 403 | 0.060 |
Why?
| | Cervical Length Measurement | 1 | 2026 | 5 | 0.060 |
Why?
| | Administration, Intravaginal | 1 | 2026 | 20 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2010 | 580 | 0.060 |
Why?
| | Pilot Projects | 1 | 2011 | 1896 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2014 | 6070 | 0.050 |
Why?
| | RNA | 1 | 2011 | 929 | 0.050 |
Why?
| | Calcium | 1 | 2010 | 1190 | 0.050 |
Why?
| | Athletic Injuries | 1 | 2010 | 571 | 0.050 |
Why?
| | Diet | 1 | 2010 | 1280 | 0.050 |
Why?
| | Health Surveys | 2 | 2014 | 518 | 0.040 |
Why?
| | Male | 5 | 2015 | 72817 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 2019 | 93 | 0.030 |
Why?
| | Risk Factors | 4 | 2015 | 10874 | 0.030 |
Why?
| | Calcium Channel Blockers | 1 | 2019 | 166 | 0.030 |
Why?
| | Public Health | 1 | 2022 | 573 | 0.030 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 344 | 0.030 |
Why?
| | Body Mass Index | 2 | 2015 | 2425 | 0.030 |
Why?
| | Bone Demineralization, Pathologic | 1 | 2015 | 2 | 0.030 |
Why?
| | Gestational Age | 1 | 2019 | 988 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2013 | 1585 | 0.030 |
Why?
| | Thinness | 1 | 2015 | 99 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 276 | 0.030 |
Why?
| | Adolescent | 4 | 2015 | 22485 | 0.030 |
Why?
| | Basketball | 1 | 2013 | 17 | 0.020 |
Why?
| | Intellectual Property | 1 | 2013 | 7 | 0.020 |
Why?
| | Dancing | 1 | 2013 | 19 | 0.020 |
Why?
| | Sex Determination Analysis | 1 | 2013 | 10 | 0.020 |
Why?
| | Gymnastics | 1 | 2013 | 20 | 0.020 |
Why?
| | Menarche | 1 | 2013 | 52 | 0.020 |
Why?
| | Physical Conditioning, Human | 1 | 2013 | 38 | 0.020 |
Why?
| | Middle Aged | 2 | 2015 | 36176 | 0.020 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 252 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2013 | 145 | 0.020 |
Why?
| | Commerce | 1 | 2013 | 80 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 79 | 0.020 |
Why?
| | Laboratories | 1 | 2013 | 110 | 0.020 |
Why?
| | Sports | 1 | 2015 | 215 | 0.020 |
Why?
| | Informed Consent | 1 | 2013 | 197 | 0.020 |
Why?
| | Iliotibial Band Syndrome | 1 | 2011 | 1 | 0.020 |
Why?
| | Fasciitis, Plantar | 1 | 2011 | 3 | 0.020 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2011 | 6 | 0.020 |
Why?
| | San Francisco | 1 | 2011 | 60 | 0.020 |
Why?
| | Feeding and Eating Disorders | 1 | 2013 | 165 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 2110 | 0.020 |
Why?
| | Incidence | 1 | 2013 | 2915 | 0.020 |
Why?
| | Health Personnel | 1 | 2013 | 750 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2950 | 0.010 |
Why?
| | Risk Assessment | 1 | 2015 | 3759 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5891 | 0.010 |
Why?
| | Military Personnel | 1 | 2010 | 737 | 0.010 |
Why?
| | Child | 1 | 2022 | 22680 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 8039 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14192 | 0.010 |
Why?
|
|
Sayres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|